ABIOMED (ABMD)
ABIOMED Debt to Equity Ratio: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ABMD Debt to Equity Ratio Rankings
| Overall | 99th percentile | 1 of 4260 |
| Sector | 99th percentile | 1 of 477 in Healthcare |
| Industry | 98th percentile | 1 of 73 in Medical Appliances & Equipment |
ABMD Debt to Equity Ratio Range, Past 5 Years
| Minimum | 0.00 | Jun 2007 |
| Maximum | 0.00 | Jun 2007 |
| Average | 0.00 |
About Debt to Equity Ratio
YCharts Calculation: Debt to Equity = (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity
The debt to equity ratio is a leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. It reveals how a company has financed its assets. A low debt to equity ratio indicates lower risk because shareholder's have claims on a larger portion of the company's assets.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
Learn More
You may also be interested in these ABMD related companies
ABMD News
$ABMD http://stks.co/3zYG volume selloff.shorting now with stop 22 .. looking for break of march support
about 2 days ago by Fernandinho
about 2 days ago by Fernandinho
$ABMD Mentioned more than normal on StockTwits - Currently at 8 x average daily social activity
about 2 days ago by TradeIdeasQuant
about 2 days ago by TradeIdeasQuant
$ABMD Prophylactic Use of Impella Achieves Cost-Effective Threshold w 58% reduction in hospitalization. http://stks.co/3zUN
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD $ABMD Reimburse. issues will be resolved. Tiny heart pump is cost-effective, saves lives. Long-term position. http://stks.co/3zU6
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD Shock patients using Impella 5.0 pump before revascularization: 65% higher survival rate.
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD Impella 5.0 catheter-based pump: 56% decrease in adverse events, 58% decrease in Class III and IV heart failure.
about 2 days ago by abubnic
about 2 days ago by abubnic
$ABMD down after Lazard analyst's downgrade from Buy to Neutral, based on rehashed concerns regarding reimbursement. Buying opp.
about 2 days ago by abubnic
about 2 days ago by abubnic
Notable Analyst Rating Changes 05/22: (MTW) (GPS) (REXX) Upgraded; (ABMD) (CBE) (LOW) Downgraded
May 22, 11:10AM Street Insider
May 22, 11:10AM Street Insider
$ABMD is 6.6% up since open on unusual high volume and 7.4% up since close.
about 10 days ago by TradeBot
about 10 days ago by TradeBot
UPDATE: Wunderlich Securities Raises PT to $29 on Abiomed; Impella Exceeds Expectations
May 17, 7:31AM Benzinga
May 17, 7:31AM Benzinga
SINA Corporation, Darden Restaurants Included in Stocks Up on High Volume Wednesday
May 16, 12:35PM Fox Business
May 16, 12:35PM Fox Business
News related to $ABMD, currently -5.6% since open: 'Abiomed posts 4Q profit; shares rise on outlook' http://stks.co/3r9p
about 11 days ago by TradeBot
about 11 days ago by TradeBot
$ABMD is -5.1% down since open on unusual high volume but still 3.4% up since close.
about 11 days ago by TradeBot
about 11 days ago by TradeBot
$ABMD finally gaining some momentum w good earnings report/strong forecast. Sees Impella Revenue up 30% in 2013. http://stks.co/3r1h
about 11 days ago by abubnic
about 11 days ago by abubnic
Listen to $ABMD Q4 2012 earnings call - live at 08:00 AM, ondemand after - http://stks.co/3qhz
about 11 days ago by earningscast
about 11 days ago by earningscast
$ABMD will begin early commercial roll-out of Impella cVAD w European physicians at the EuroPCR in Paris on May 15-18. http://stks.co/3nVP
about 15 days ago by abubnic
about 15 days ago by abubnic
Abiomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 10, 8:00AM GlobeNewswire
May 10, 8:00AM GlobeNewswire
Abiomed Announces Participation in Three Upcoming Physician Society Meetings: SCAI, HRS, & EuroPCR
May 08, 4:02PM GlobeNewswire
May 08, 4:02PM GlobeNewswire
Abiomed Fourth Quarter and Full Fiscal Year 2012 Earnings and Conference Call Notification
May 08, 8:00AM GlobeNewswire
May 08, 8:00AM GlobeNewswire
$ABMD CEO presents at the Deutsche Bank Healthcare
Conference on May 8. http://stks.co/3gLI
about 22 days ago by abubnic
about 22 days ago by abubnic
Tiny $ABMD heart pump saves Covington woman's life. http://stks.co/3ZaD
about 27 days ago by abubnic
about 27 days ago by abubnic
Jeffries boosted target price for $ABMD this week to $28 on growth prospects, citing convergence of positive factors. http://stks.co/3ZaC
about 27 days ago by abubnic
about 27 days ago by abubnic
Rival heart pump makers $ABMD and $THOR get a boost after FDA panel recommends HeartWare's HVAD device for approval. http://stks.co/3YBD
about 30 days ago by abubnic
about 30 days ago by abubnic
Can Heart Pump Stocks Pump Up Your Portfolio? Heart pump stocks $HRWR $THOR & $ABMD have plenty of potential customers. http://stks.co/3TiE
about 33 days ago by abubnic
about 33 days ago by abubnic
$ABMD http://stks.co/3TON @BenCBanks yes it has that Dollar range over 22.50
about 33 days ago by StockTiger
about 33 days ago by StockTiger
@1nvestor I agree with $ABMD - with this short interest we could really see a pop in coming days/weeks if we break the spprt.
about 33 days ago by BenCBanks
about 33 days ago by BenCBanks
Wedge formed abv B/O level. Now back over 50d. RSI ^ $ABMD http://chart.ly/lx3k2nl
about 33 days ago by 1nvestor
about 33 days ago by 1nvestor
Abiomed Appoints Susan Vissers Lisa as Senior Director of Investor Relations and Corporate Development
Mar 21, 8:00AM Business Wire
Mar 21, 8:00AM Business Wire
Abiomed Announces Schedule of Events at American College of Cardiology 2012 Scientific Sessions
Mar 20, 8:00AM Business Wire
Mar 20, 8:00AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABMD | 20.80 | -1.12 | -5.11% | 810.99M |
| ABM | 21.73 | +0.05 | +0.23% | 1.159B |
| ABIO | 0.69 | +0.14 | +25.45% | 7.259M |
| ABH | 11.83 | +0.00 | +0.00% | 1.149B |
| ABFS | 12.99 | +0.15 | +1.17% | 330.60M |
| ABD | 9.40 | -0.08 | -0.84% | 523.11M |
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ACH | 10.07 | -0.25 | -2.42% | 1.589B |
| ACGL | 38.31 | -0.31 | -0.80% | 5.188B |
| ACG | 8.20 | +0.00 | +0.00% |